Independent Advisor Alliance’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $23M | Buy |
91,394
+2,672
| +3% | +$575K | 0.54% | 26 |
|
|
2026
Q1 | $19.3M | Sell |
88,722
-23,996
| -21% | -$5.32M | 0.21% | 99 |
|
|
2025
Q4 | $25.8M | Sell |
112,718
-4,153
| -4% | -$946K | 0.63% | 22 |
|
|
2025
Q3 | $27.1M | Buy |
116,871
+2,966
| +3% | +$604K | 0.7% | 22 |
|
|
2025
Q2 | $21.1M | Sell |
113,905
-1,578
| -1% | -$293K | 0.61% | 25 |
|
|
2025
Q1 | $24.2M | Sell |
115,483
-9,334
| -7% | -$1.81M | 0.8% | 23 |
|
|
2024
Q4 | $22.2M | Buy |
124,817
+8,480
| +7% | +$1.56M | 0.29% | 68 |
|
|
2024
Q3 | $23M | Sell |
116,337
-660
| -0.6% | -$123K | 0.84% | 21 |
|
|
2024
Q2 | $20.1M | Buy |
116,997
+2,595
| +2% | +$430K | 0.69% | 28 |
|
|
2024
Q1 | $20.8M | Sell |
114,402
-6,765
| -6% | -$1.17M | 0.75% | 28 |
|
|
2023
Q4 | $18.8M | Buy |
121,167
+473
| +0.4% | +$69K | 0.68% | 32 |
|
|
2023
Q3 | $18M | Sell |
120,694
-3,350
| -3% | -$492K | 0.81% | 24 |
|
|
2023
Q2 | $16.7M | Sell |
124,044
-1,279
| -1% | -$188K | 0.74% | 28 |
|
|
2023
Q1 | $20M | Buy |
125,323
+3,076
| +3% | +$470K | 0.96% | 20 |
|
|
2022
Q4 | $19.8K | Sell |
122,247
-4,461
| -4% | -$684K | 0.01% | 155 |
|
|
2022
Q3 | $17M | Sell |
126,708
-11,439
| -8% | -$1.64M | 0.99% | 16 |
|
|
2022
Q2 | $21.2M | Buy |
138,147
+17,335
| +14% | +$2.65M | 1.18% | 13 |
|
|
2022
Q1 | $19.6M | Buy |
120,812
+11,891
| +11% | +$1.73M | 0.94% | 18 |
|
|
2021
Q4 | $14.7M | Buy |
108,921
+8,069
| +8% | +$953K | 0.73% | 31 |
|
|
2021
Q3 | $10.9M | Buy |
100,852
+1,346
| +1% | +$154K | 0.6% | 37 |
|
|
2021
Q2 | $11.2M | Sell |
99,506
-15,008
| -13% | -$1.69M | 0.61% | 32 |
|
|
2021
Q1 | $12.4M | Buy |
114,514
+11,509
| +11% | +$1.23M | 0.74% | 29 |
|
|
2020
Q4 | $11M | Buy |
103,005
+7,259
| +8% | +$698K | 0.75% | 29 |
|
|
2020
Q3 | $8.39M | Buy |
95,746
+52,203
| +120% | +$4.91M | 0.64% | 43 |
|
|
2020
Q2 | $4.28M | Buy |
43,543
+7,680
| +21% | +$676K | 0.46% | 44 |
|
|
2020
Q1 | $2.73M | Sell |
35,863
-4,297
| -11% | -$366K | 0.4% | 56 |
|
|
2019
Q4 | $3.56M | Sell |
40,160
-1,795
| -4% | -$149K | 0.16% | 145 |
|
|
2019
Q3 | $3.21M | Sell |
41,955
-2,480
| -6% | -$170K | 0.39% | 56 |
|
|
2019
Q2 | $2.89M | Sell |
44,435
-3,191
| -7% | -$251K | 0.42% | 49 |
|
|
2019
Q1 | $3.84M | Buy |
47,626
+4,836
| +11% | +$396K | 0.54% | 41 |
|
|
2018
Q4 | $3.89M | Sell |
42,790
-1,774
| -4% | -$156K | 0.69% | 35 |
|
|
2018
Q3 | $3.89M | Buy |
44,564
+4,784
| +12% | +$454K | 0.7% | 34 |
|
|
2018
Q2 | $3.35M | Buy |
39,780
+3,775
| +10% | +$369K | 0.7% | 34 |
|
|
2018
Q1 | $3.29M | Buy |
36,005
+1,245
| +4% | +$137K | 0.73% | 35 |
|
|
2017
Q4 | $3.46M | Buy |
34,760
+9,546
| +38% | +$900K | 0.77% | 32 |
|
|
2017
Q3 | $2.29M | Buy |
25,214
+5,493
| +28% | +$418K | 0.63% | 37 |
|
|
2017
Q2 | $1.42M | Sell |
19,721
-3,647
| -16% | -$245K | 0.45% | 71 |
|
|
2017
Q1 | $1.52M | Buy |
23,368
+6,327
| +37% | +$398K | 0.24% | 124 |
|
|
2016
Q4 | $1.04M | Buy |
+17,041
| New | +$1.04M | 0.45% | 69 |
|
Other funds holding ABBV
Independent Advisor Alliance's ABBV Position: Q2 2026 in Review
Independent Advisor Alliance increased its AbbVie (ABBV) stake by 3% in Q2 2026, buying an estimated $575K and bringing the position to 91,394 shares worth $23M. The position accounts for 0.54% of the portfolio, ranked #26.
Independent Advisor Alliance first reported a position in ABBV in Q4 2016 and has held it in 39 quarters since. The position peaked at $27.1M in Q3 2025. 4,189 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Independent Advisor Alliance held 91,394 shares of AbbVie worth $23M as of Q2 2026.
- Independent Advisor Alliance bought 2,672 AbbVie shares in Q2 2026, an estimated $575K.
- AbbVie made up 0.54% of Independent Advisor Alliance's portfolio in Q2 2026, its #26 holding.
- Independent Advisor Alliance first reported a position in AbbVie in Q4 2016 and has held it in 39 quarters since.
- Independent Advisor Alliance's AbbVie position peaked at $27.1M in Q3 2025.
- 4,189 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Independent Advisor Alliance's 13F filing for Q2 2026, filed 12 Aug 2026.